Orlando medical firm Lensar goes public to help fund ‘next-generation’ eye surgery tech

Orlando is home to a new public company, as medical tech firm Lensar Inc. spins off from its former parent company with plans to grow. 

Lensar (Nasdaq: LNSR) completed its separation from Incline Village, Nevada-based PDL BioPharma Inc. on Oct. 1 and subsequently began trading on the Nasdaq, according to an Oct. 2 filing with the U.S. Securities and Exchange Commission. It’s the latest Orlando-based business to go public, a phenomenon not too common in Central Florida.  Read more here.